Protein kinase C (PKC) has been hypothesized to be involved in the regulation of tonic contraction in vascular smooth muscle. The data supporting this are indirect and are derived mainly from studies characterizing the contractile effects of certain phorbol esters which are presumably specific activators of PKC. In addition, studies of hormone-response coupling and PKC activation in response to Ca2+-dependent activators in other cell types support the concept that Ca2+-dependent contractile agonists could activate PKC in vascular smooth muscle. The broad goals of the proposed research are to determine if PKC activation in vascular smooth muscle occurs as a consequence of stimulation by physiologically relevant stimuli, and if so, whether PKC activation is involved in the regulation of contractile function. Specifically, the proposed studies include experiments to directly estimate PKC activation in response agonists or membrane depolarization in intact functional preparations of arterial smooth muscle. PKC activation will be assessed by: 1) measuring the translocation of activated PKC from cytosol to membranes; 2) measuring the phosphorylation of specific PKC substrates; and, 3) by measuring accumulation of the endogenous activator, diacylglycerol. The involvement of PKC in regulating contractile function will be tested by correlating PKC activity with mechanical indices of activation, by assessing the effects of putative PKC inhibitors on PKC activity and function, and by determining the mechanisms by which specific activators of PKC (phorbol esters) contract vascular smooth muscle. The role of extracellular and intracellular Ca2+ in regulating PKC activation and/or metabolism to PKM, the irreversibly activated proteolytic fragment of PKC, will be determined. Details regarding this aspect of signal transduction in normal vascular smooth muscle may ultimately be important in understanding pathology associated with vascular diseases such as hypertension or atherosclerosis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL040992-01
Application #
3358405
Study Section
Experimental Cardiovascular Sciences Study Section (ECS)
Project Start
1988-07-01
Project End
1991-06-30
Budget Start
1988-07-01
Budget End
1989-06-30
Support Year
1
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Geisinger Medical Center
Department
Type
DUNS #
City
Danville
State
PA
Country
United States
Zip Code
17822
Ginnan, Roman; Guikema, Benjamin J; Halligan, Katharine E et al. (2008) Regulation of smooth muscle by inducible nitric oxide synthase and NADPH oxidase in vascular proliferative diseases. Free Radic Biol Med 44:1232-45
Ginnan, Roman; Guikema, Benjamin J; Singer, Harold A et al. (2006) PKC-delta mediates activation of ERK1/2 and induction of iNOS by IL-1beta in vascular smooth muscle cells. Am J Physiol Cell Physiol 290:C1583-91
Ginnan, Roman; Singer, Harold A (2005) PKC-delta-dependent pathways contribute to PDGF-stimulated ERK1/2 activation in vascular smooth muscle. Am J Physiol Cell Physiol 288:C1193-201
Ginnan, Roman; Pfleiderer, Paul J; Pumiglia, Kevin et al. (2004) PKC-delta and CaMKII-delta 2 mediate ATP-dependent activation of ERK1/2 in vascular smooth muscle. Am J Physiol Cell Physiol 286:C1281-9
Ginnan, Roman; Singer, Harold A (2002) CaM kinase II-dependent activation of tyrosine kinases and ERK1/2 in vascular smooth muscle. Am J Physiol Cell Physiol 282:C754-61
Rokolya, A; Walsh, M P; Singer, H A et al. (1998) Protein kinase C--catalyzed calponin phosphorylation in swine carotid arterial homogenate. J Cell Physiol 176:545-52
Bhat, G J; Abraham, S T; Singer, H A et al. (1997) Alpha-thrombin stimulates sis-inducing factor-A DNA binding activity in rat aortic smooth muscle cells. Hypertension 29:356-60
Busuttil, S J; Morehouse, D L; Youkey, J R et al. (1996) Antisense suppresssion of protein kinase C-alpha and -delta in vascular smooth muscle. J Surg Res 63:137-42
Schorb, W; Conrad, K M; Singer, H A et al. (1995) Angiotensin II is a potent stimulator of MAP-kinase activity in neonatal rat cardiac fibroblasts. J Mol Cell Cardiol 27:1151-60
Booz, G W; Taher, M M; Baker, K M et al. (1994) Angiotensin II induces phosphatidic acid formation in neonatal rat cardiac fibroblasts: evaluation of the roles of phospholipases C and D. Mol Cell Biochem 141:135-43

Showing the most recent 10 out of 18 publications